Metabolic Acidosis Is an Independent Risk Factor of Renal Progression in Korean Chronic Kidney Disease Patients: The KNOW-CKD Study Results
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- FRONTIERS IN MEDICINE8 · 2021
- 피인용
- Web of Science 15Scopus 16
- FWCI (Scopus)
- 1.29
- JCR IF
- JCR 2020 5.093
- ISSN
- 2296-858X
저자
- 김효진제1저자Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea
- Ryu, HyunjinSeoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
- Kang, EunjeongEwha Womans Univ, Seoul Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
- Kang, MinjungSeoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
- 한미연Hallym Univ, Dept Internal Med, Hangang Sacred Heart Hosp, Seoul, South Korea
- 송상헌Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea
- Lee, JoongyubSeoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea
- Jung, Ji YongGachon Univ, Coll Med, Dept Internal Med, Gil Med Ctr, Incheon, South Korea
- Lee, Kyu-BeckSungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea
- Sung, SuahEulji Univ, Eulji Med Ctr, Dept Internal Med, Seoul, South Korea
- 성은영Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea
- Ahn, CurieNatl Med Ctr, Dept Internal Med, Seoul, South Korea
- Oh, Kook-Hwan교신저자Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
초록
© Copyright © 2021 Kim, Ryu, Kang, Kang, Han, Song, Lee, Jung, Lee, Sung, Seong, Ahn and Oh.Background: We aimed to evaluate serum bicarbonate as a risk factor for renal progression, cardiovascular events, and mortality in Korean CKD patients. Methods: We analyzed 1,808 participants from a Korean CKD cohort whose serum bicarbonate levels were measured at enrollment. Serum bicarbonate levels were categorized as low, lower normal, higher normal, and high (total carbon dioxide <22, 22–26, 26.1–29.9, and ≥30 mmol/L, respectively) groups. Metabolic acidosis was defined as a serum bicarbonate level <22 mmol/L. The primary outcome was renal events defined as doubling of serum creatinine, 50% reduction of eGFR from the baseline values, or development of end-stage kidney disease. The secondary outcome consisted of cardiovascular events and death. In addition, patients whose eGFR values were measured more than three times during the follow-up period were analyzed for eGFR decline. The rapid decline in eGFR was defined as lower than the median value of the eGFR slope. Results: The mean serum bicarbonate level was 25.7 ± 3.7 mmol/L and 240 (13.2%) patients had metabolic acidosis. During the follow-up period of 55.2 ± 24.1 months, 545 (30.9%) patients developed renal events and 187 (10.6%) patients developed a composite of cardiovascular events and death. After adjustment, the low serum bicarbonate group experienced 1.27 times more renal events than the lower normal bicarbonate group [hazard ratio (HR): 1.27; 95% CI: 1.01–1.60, P = 0.043]. There was no significant association between the bicarbonate groups and the composite outcome of cardiovascular events and death. The low bicarbonate group showed a significantly rapid decline in eGFR [odds ratio (OR): 2.12; 95% CI: 1.39–3.22, P < 0.001] compared to the lower normal bicarbonate group. Conclusions: Metabolic acidosis was significantly associated with increased renal events and a rapid decline in renal function in Korean predialysis CKD patients.
키워드
chronic kidney diseasemetabolic acidosisrenal function declinerenal progressionserum bicarbonateSERUM BICARBONATE LEVELSFUNCTION DECLINEBASE-BALANCEOUTCOMESASSOCIATIONINFLAMMATIONPREVALENCEMORTALITY
식별자
- Scopus EID
- 2-s2.0-85112420801
- WoS UID
- 000684669900001



로그인
연구물 목록으로